Canna~Fangled Abstracts Cannabinoids and Chronic Liver Diseases Review Int J Mol Sci. 2022 Aug 20;23(16):9423. doi: 10.3390/ijms23169423. Ralph-Sydney Mboumba Bouassa 1 2, Giada Sebastiani 2 3 4, Vincenzo Di…Freedom WaresAugust 20, 2022
Canna~Fangled Abstracts Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research Editorial Fabienne Marcellin, Hélène Fontaine, Lawrence Serfaty, Philippe Sogni & Maria Patrizia Carrieri Received 22…Freedom WaresMay 9, 2018
Canna~Fangled Abstracts No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). 2016 Apr 13. doi: 10.1111/dar.12398. Marcellin F1,2,3, Lions C1,2,3, Rosenthal E4,5, Roux P1,2,3, Sogni P6, Wittkop L7,8, Protopopescu C1,2,3, Spire B1,2,3, Salmon-Ceron D9,10, Dabis…Freedom WaresApril 13, 2016
Canna~Fangled Abstracts Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus. Can J Gastroenterol. 2008 April; 22(4): 376–380. PMCID: PMC2662895 Evaluation of oral cannabinoid-containing medications for the management of…Freedom WaresSeptember 9, 2013